Anxiolytic and antidepressant effects of intracerebroventricularly administered somatostatin: Behavioral and neurophysiological evidence

Somatostatin (SST) is a cyclic polypeptide that inhibits the release of a variety of regulatory hormones (e.g. growth hormone, insulin, glucagon, thyrotropin). Moreover, SST is widely distributed within the CNS, acting both as a neurotransmitter and as a neuromodulator of other neurotransmitter systems. However, despite its extensive expression in limbic areas, and its co-localization with GABA, a neurotransmitter previously implicated in emotion, the effects of SST on anxiety and depression have not been investigated. By performing intraventricular infusions in rats we demonstrate, for the first time, that SST has anxiolytic- and antidepressant-like effects in the elevated plus-maze and forced swim test, respectively. In addition, by performing local field potential recordings of hippocampal theta activity evoked by reticular stimulation in urethane-anesthetized rats we also show that SST application suppresses the frequency of theta in a similar fashion to diazepam. This neurophysiological signature, common to all classes of anxiolytic drugs (i.e. benzodiazepines, selective 5-HT reuptake inhibitors, 5-HT1A agonists) provides strong converging evidence for the anxiolytic-like characteristics of SST. Our pharmacological antagonism experiments with bicuculline further suggest that the anxiolytic effect of SST may be attributable to the interaction of SST with GABA, whereas the antidepressant-like effect of SST may be GABA-independent. In addition to contributing to the current understanding of the role of neuropeptides in mood and emotion, these findings support a clinical role for SST (or its analogues) in the treatment of anxiety and depression.

[1]  A. Beaudet,et al.  Immunohistochemical distribution of the somatostatin receptor subtype 5 in the adult rat brain: Predominant expression in the basal forebrain , 1999, The Journal of comparative neurology.

[2]  M. Chesselet,et al.  Somatostatin regulates dopamine release in rat striatal slices and cat caudate nuclei , 1983, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[3]  H. Pape,et al.  Mechanisms of somatostatin‐evoked responses in neurons of the rat lateral amygdala , 2005, The European journal of neuroscience.

[4]  D. Treit,et al.  The effects of intra-cerebral drug infusions on animals' unconditioned fear reactions: A systematic review , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[5]  S. File,et al.  Validation of open : closed arm entries in an elevated plus-maze as a measure of anxiety in the rat , 1985, Journal of Neuroscience Methods.

[6]  R. Numan.  The Behavioral Neuroscience of the Septal Region , 2012, Springer New York.

[7]  D. Cain,et al.  Water maze impairments after combined depletion of somatostatin and serotonin in the rat , 2007, Behavioural Brain Research.

[8]  V. Gribkoff,et al.  Cognition-enhancing drugs increase stimulated hippocampal theta rhythm amplitude in the urethane-anesthetized rat. , 1999, The Journal of pharmacology and experimental therapeutics.

[9]  Somatostatin in the Pontine Reticular Formation Modulates Fear Potentiation of the Acoustic Startle Response: An Anatomical, Electrophysiological, and Behavioral Study , 1996, The Journal of Neuroscience.

[10]  S. Belcheva,et al.  Differential effects of somatostatin on exploratory behavior after unilateral injections into rat neostriatum , 2004, Peptides.

[11]  D. Treit,et al.  The anxiolytic effects of intra-hippocampal midazolam are antagonized by intra-septal l-glutamate , 2001, Brain Research.

[12]  S. Lamberts,et al.  Novel subtype specific and universal somatostatin analogues: clinical potential and pitfalls. , 2005, Current pharmaceutical design.

[13]  E. Pintér,et al.  Inhibitory effect of somatostatin on inflammation and nociception. , 2006, Pharmacology & therapeutics.

[14]  G. Siggins,et al.  Somatostatin acts in CA1 and CA3 to reduce hippocampal epileptiform activity. , 1999, Journal of neurophysiology.

[15]  C. Houser,et al.  Somatostatin neurons are a subpopulation of GABA neurons in the rat dentate gyrus: Evidence from colocalization of pre-prosomatostatin and glutamate decar☐ylase messenger RNAs , 1995, Neuroscience.

[16]  T. Porkka-Heiskanen,et al.  Intracerebroventricular and Locus Coeruleus Microinjections of Somatostatin Antagonist Decrease REM Sleep in Rats , 2000, Pharmacology Biochemistry and Behavior.

[17]  C. Stewart,et al.  Repeated ECS and fluoxetine administration have equivalent effects on hippocampal synaptic plasticity , 2000, Psychopharmacology.

[18]  D. Treit,et al.  Anxiety is functionally segregated within the septo-hippocampal system , 2004, Brain Research.

[19]  M. Rodríguez‐Puyol,et al.  Acute modulation of somatostatin receptor function by melatonin in the rat frontoparietal cortex , 2001, Journal of pineal research.

[20]  J. Bertherat,et al.  Regulation of somatostatin synthesis by GABAA receptor stimulation in mouse brain. , 1992, Brain research. Molecular brain research.

[21]  I. Lucki.  The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. , 1997, Behavioural pharmacology.

[22]  D. Treit,et al.  Septal gabaergic and hippocampal cholinergic systems interact in the modulation of anxiety , 2003, Neuroscience.

[23]  Christian Bruns,et al.  Opportunities in somatostatin research: biological, chemical and therapeutic aspects , 2003, Nature Reviews Drug Discovery.

[24]  A. Strosberg,et al.  University of Groningen Coexistence of muscarinic acetylcholine receptors and somatostatin in nonpyramidal neurons of the rat dorsal hippocampus , 2002 .

[25]  R. Porsolt,et al.  Behavioural despair in rats: a new model sensitive to antidepressant treatments. , 1978, European journal of pharmacology.

[26]  N. Matsuoka,et al.  Changes in brain somatostatin in memory-deficient rats: comparison with cholinergic markers , 1995, Neuroscience.

[27]  Ling Lin,et al.  Effects of exogenous hyaluronan on midline crossing and axon divergence in the optic chiasm of mouse embryos , 2007, The European journal of neuroscience.

[28]  J. Billard,et al.  Involvement of sst2 somatostatin receptor in locomotor, exploratory activity and emotional reactivity in mice , 2000, The European journal of neuroscience.

[29]  D. Hoyer,et al.  Brain somatostatin: a candidate inhibitory role in seizures and epileptogenesis , 1999, The European journal of neuroscience.

[30]  A. Armario,et al.  Rapid modifications of somatostatin neuron activity in the periventricular nucleus after acute stress , 2000, Experimental Brain Research.

[31]  K. Ressler,et al.  Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders , 2000, Depression and anxiety.

[32]  Y. Lamour,et al.  Correlations between Water Maze Performance and Cortical Somatostatin mRNA and High‐affinity Binding Sites During Ageing in Rats , 1996, The European journal of neuroscience.

[33]  M. Lader.  Benzodiazepines , 1994 .

[34]  J. Reubi,et al.  Autoradiographic mapping of somatostatin receptors in the rat central nervous system and pituitary , 1985, Neuroscience.

[35]  G. Siggins,et al.  Somatostatin depresses excitatory but not inhibitory neurotransmission in rat CA1 hippocampus. , 1997, Journal of neurophysiology.

[36]  D. Cain.  Prior non-spatial pretraining eliminates sensorimotor disturbances and impairments in water maze learning caused by diazepam , 1997, Psychopharmacology.

[37]  N. McNaughton,et al.  Reticular stimulation and hippocampal theta rhythm in rats: Effects of drugs , 1978, Neuroscience.

[38]  P. Emson,et al.  Immunohistochemical localization of the somatostatin sst2(a) receptor in the rat brain and spinal cord 1 Parts of these results have been presented in abstract form to the British Pharmacological Society, Brighton/UK, December 1995 1 , 1996, Neuroscience.

[39]  L. Givalois,et al.  Acute stress and dexamethasone rapidly increase hippocampal somatostatin synthesis and release from the dentate gyrus hilus , 2001, Hippocampus.

[40]  D. Treit,et al.  Dissociations among the anxiolytic effects of septal, hippocampal, and amygdaloid lesions , 1997 .

[41]  J. Pujol,et al.  Quantitative autoradiography of somatostatin receptors in the rat limbic system , 1993, The Journal of comparative neurology.

[42]  C. Rougeot,et al.  Chronic stress affects in vivo hypothalamic somatostatin release but not in vitro GH responsiveness to somatostatin in rats , 1993, Neuroscience Letters.

[43]  N. Matsuoka,et al.  Possible involvement of brain somatostatin in the memory formation of rats and the cognitive enhancing action of FR121196 in passive avoidance task , 1994, Brain Research.

[44]  D. Treit,et al.  The Septum and Anxiety , 2000 .

[45]  G. Telegdy,et al.  Effects of somatostatin and anti-somatostatin serum on picrotoxin-kindled seizures , 1992, Neuropharmacology.

[46]  T. Batten,et al.  Evidence for peptide co-transmission in retrograde- and anterograde-labelled central nucleus of amygdala neurones projecting to NTS , 2002, Autonomic Neuroscience.

[47]  J. Gray,et al.  Précis of The neuropsychology of anxiety: An enquiry into the functions of the septo-hippocampal system , 1982, Behavioral and Brain Sciences.

[48]  F. Mascagni,et al.  Immunohistochemical characterization of somatostatin containing interneurons in the rat basolateral amygdala , 2002, Brain Research.

[49]  Bernat Kocsis,et al.  Elicited hippocampal theta rhythm: a screen for anxiolytic and procognitive drugs through changes in hippocampal function? , 2007, Behavioural pharmacology.

[50]  D. Marazziti,et al.  Do animal models of anxiety predict anxiolytic-like effects of antidepressants? , 2002, Psychopharmacology.

[51]  E. Brodin,et al.  Effects of sequential removal of rats from a group cage, and of individual housing of rats, on substance P, cholecystokinin and somatostatin levels in the periaqueductal grey and limbic regions , 1994, Neuropeptides.

[52]  D. Treit,et al.  The neuroanatomical specificity of the anxiolytic effects ofintra-septal infusions of midazolam , 1996, Brain Research.

[53]  B. Winblad,et al.  Environmental influence on somatostatin levels and gene expression in the rat brain , 1993, Brain Research.

[54]  A. Steiger,et al.  Somatostatin Impairs Sleep in Elderly Human Subjects , 1997, Neuropsychopharmacology.

[55]  K. Milenov,et al.  Behavioral effects of somatostatin microinjected into caudate putamen , 2001, Neuropeptides.

[56]  N. Ling,et al.  Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone , 1973, Science.

[57]  M. Simonato,et al.  On the Role of Somatostatin in Seizure Control: Clues from the Hippocampus , 2003, Reviews in the neurosciences.

[58]  D. K. Meyer,et al.  Effects of somatostatin-14 on the in vitro release of [3H]GABA from slices of rat caudatoputamen , 1989, Neuroscience.

[59]  B. R. Sastry,et al.  Actions of somatostatin on GABA-ergic synaptic transmission in the CA1 area of the hippocampus , 1992, Brain Research.

[60]  P. Rocca,et al.  Paroxetine efficacy in the treatment of generalized anxiety disorder , 1997, Acta psychiatrica Scandinavica.